Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    World of Coffee Dubai 2026 continued its strong momentum on Day Two at Dubai World Trade Centre, delivering a programme firmly centred on trade, origin engagement, and professional development. Organised by DXB LIVE, the integrated event management and experiential agency of Dubai World Trade Centre (DWTC), in collaboration with the Specialty Coffee Association (SCA), the […] The post The Fifth Edition Wraps Up a Pivotal Second Day Focused on Trade, Auctions, Origin Engagement, and Professional Learning appeared first on Web-Release.